Serial casted scar
OtherAt the preselected treatment site, a serial cast will be applied by a trained OT and worn by participant for 7 days.
NCT Number: NCT07645664
Scar management remains one of the major clinical challenges for burn survivors with hypertrophic scars. Beyond their visible appearance, hypertrophic scars can significantly impair physical function, reduce life satisfaction, and affect overall quality of life. According to the results of a recently completed study, the application of serial casts appears promising for the treatment of hypertrophic scars in adults who have survived a burn injury. However, this therapeutic approach has not yet been evaluated objectively in terms of scar characteristics within the context of a study with sufficient statistical power. The present project is the first study with sufficient statistical power to objectively evaluate the beneficial effects of serial casting on the characteristics of hypertrophic scars in adult burn survivors. The objective of this study is to characterize changes in thickness, elasticity, vascularization, transepidermal water loss (TEWL), itching, and pain in hypertrophic burn scars in adults after one week of treatment with serial dressings, compared to an intra-individual control scar. Our hypothesis is that relative to baseline measures the scar thickness (primary outcome), erythema index, TEWL, itch, and pain will decrease at treatment sites compared to control sites. Conversely, elasticity will increase at the treatment sites compared to control sites. This will be a prospective, longitudinal, evaluator-blinded, randomized intra-individual controlled trial.
Trial opening soon.
Get Notified16 year and older
All sexes
Interventional
Not applicable
This will be a prospective, longitudinal, evaluator-blinded, randomized intra-individual controlled trial. Participants will start serial casting on selected scars during 7 days for 24 hrs/day. The objective scar characteristics and the subjective scar quality appreciation level will be evaluated immediately before and immediately after serial casting, and then 3 weeks after the cast has been removed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At the preselected treatment site, a serial cast will be applied by a trained OT and worn by participant for 7 days.
Time frame: right before intervention, right after intervention, three weeks after intervention
Ultrasound skin thickness (mm) measured by Dermascan
Time frame: right before intervention, right after intervention, three weeks after intervention
Subjective Scar Satisfaction Level evaluated by POSAS (Patient and Observer Scar Assessment Scale) v. 2.0 modified; visual analog scale (score 0-identical to- 10-very different from normal skin).
Time frame: right before intervention, right after intervention, three weeks after intervention
Erythema index measure by Mexameter, values from 0 to 999. The erythema values are individual for each person and depend strongly on the skin type. The measurements are generally used to determine changes before and after a treatment.
Time frame: right before intervention, right after intervention, three weeks after intervention
Trans-epidermal water loss (TEWL) measured by Tewameter.
Time frame: right before intervention, right after intervention, three weeks after intervention
Melanin index measured by Mexameter
Time frame: right before intervention, right after intervention, three weeks after intervention
Skin elasticity measures (mm) measured by Cutometer (r0)
Contact information is provided by the study sponsor or research team.
Centre hospitalier de l'Université de Montréal (CHUM)
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01619917
Burn Scar, Burns
Winnipeg, Manitoba, Canada
View Trial DetailsNCT01488240
Burn Scar, Burns
Winnipeg, Manitoba, Canada
View Trial DetailsNCT06807021
Burn Scar, Burn Wound
Edmonton, Alberta, Canada
View Trial DetailsNCT07234305
Burn Scar, Burns
Cairo, Egypt
View Trial Details